Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell AbCellera Biologics Inc (ABCL) – AbCellera Biologics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbCellera Biologics (ABCL) trades at $5.42, down 3.56% today, with a bullish technical outlook supported by golden cross formation and strong analyst consensus. The company shows improving revenue trends ($75M in 2025 vs $29M in 2024) and beat Q1 2026 earnings expectations, though remains unprofitable with negative margins. Recent developments include positive Phase 1 data for lead program ABCL635 and board appointments signaling strategic focus.
While ABCL faces significant execution risks in drug development and negative cash flow, Wall Street maintains strong bullish sentiment with 82% buy ratings and $9.00 consensus target representing 66% upside. The transition to proprietary drug development creates both opportunity for substantial returns and risk of continued losses if clinical milestones aren't met.
Read full analysis

Key Stats

  • Market Cap
    $1.72B
  • Sector
    Health
  • 3M Drawdown
    -22.86%
  • Enterprise Value
    $1.35B
  • Dividend Yield
    -
  • Trading Activity
    93% Buy | 7% Sell
  • Typical Hold Time
    39 days
$5.48
52W Low: $2.44
06 Jun 2025
52W High: $6.46
01 Jun 2026

AbCellera Biologics Inc (ABCL) is currently valued at a market capitalization of $1.72B, with an enterprise value of $1.35B. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.44 and a high of $6.46, highlighting its annual price range. Over the past three months, AbCellera Biologics Inc has recorded a drawdown of -22.86%, reflecting recent price volatility. On average, investors hold AbCellera Biologics Inc for approximately 39 days, indicating typical investor behavior on the platform.

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.72B
  • Sector
    Health
  • 3M Drawdown
    -22.86%
  • Enterprise Value
    $1.35B
  • Dividend Yield
    -
  • Trading Activity
    93% Buy | 7% Sell
  • Typical Hold Time
    39 days
$5.48
52W Low: $2.44
06 Jun 2025
52W High: $6.46
01 Jun 2026

AbCellera Biologics Inc (ABCL) is currently valued at a market capitalization of $1.72B, with an enterprise value of $1.35B. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.44 and a high of $6.46, highlighting its annual price range. Over the past three months, AbCellera Biologics Inc has recorded a drawdown of -22.86%, reflecting recent price volatility. On average, investors hold AbCellera Biologics Inc for approximately 39 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!